Home > Healthcare > Medical Devices > Medical Equipment > Cell Washers Market

Cell Washers Market Trends

Report ID: GMI9399
Published Date: May 2024
Report Format: PDF

Download Free Sample

Cell Washers Market Trends

Advancements in efficiency, reliability, and ease of use have propelled significant growth in the market. Integration of automation and robotics enhances throughput and reduces errors, while tailored washing protocols ensure cell viability. Features such as closed-system designs and sterilization mechanisms minimize contamination risks.
Fresenius SE & Co. KGaA's LOVO Automated Cell Processing System exemplifies this progress, revolutionizing the washing and concentration of white blood cell products.
Thus, ongoing innovation in cell washer technology not only meets the needs of research and clinical environments but also fosters advancements in fields such as cell biology and regenerative medicine.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Cell washers market size was USD 257.9 million in 2023 and is expected to register 4.8% CAGR from 2024-2032 owing to the increasing prevalence of chronic diseases such as anemia, cancer, hemophilia, and sickle cell disease worldwide.

Cell washers industry from the consumables segment is expected to record USD 211.3 million by 2032 due to a surge in adoption of cell washing techniques across diverse biomedical and clinical research domains.

North America cell washers industry is expected to reach USD 116.5 million by 2032 due to rising number of cancer diagnoses and increasing need for chemotherapy in the region.

CYTENA GmbH, Danaher Corporation, Fresenius SE & Co. KGaA, Haemonetics Corporation, Helmer Scientific Inc., Labtron Equipment Ltd., LivaNova PLC, Labozon Scientific Inc., Medfuture Biotech Co., Ltd., and Terumo Corporation, are some of the major cell washers companies worldwide.